Skip to main content
. 2006 Jan 31;94(4):455–459. doi: 10.1038/sj.bjc.6602970

Table 1. Somatic mutations of PIK3CA in cancer types reported since 10/2005.

Cancer % PIK3CA mutationa Sample source (primary tissue vs cancer cell line) Exon mutated Functional domain Reference
Liver 35.6 (26/73) Primary 9 and 20 Helical and kinase Lee et al (2004)
           
Total liver 36% (26/73)
           
Breast 33.3 (4/12) Cell lines 9 and 20 Helical and kinase Bachman et al (2004)
Breast 21.4 (9/42) Primary 1, 9 and 20 p85, helical and kinase Bachman et al (2004)
Breast 18.1 (13/72) Primary 9 and 20 Helical and kinase Levine et al (2005)
Breast 40.0 (28/70) Primary 6, 7, 9 and 20 C2, helical and kinase Campbell et al (2004)
Breast 20.7 (19/92) Primary 9 and 20 Helical and kinase Wu et al (2005a)
Breast 8.3 (1/12) Primary 20 kinase Samuels et al (2004)
Breast 33.3 (5/15) Cell lines 9 and 20 Helical and kinase Wu et al (2005a)
Breast 26.9 (25/93) Primary 9 and 20 Helical and kinase Lee et al (2004)
Breast 28.0 (14/50) Cell lines 1, 9 and 20 p85, helical and kinase Saal et al (2005)
Breast 26.4 (77/292) Primary 1, 4, 7, 9, 13, 18, 20 p85, C2, helical and kinase Saal et al (2005)
           
Total breast 26% (195/750)
           
Colon 31.6 (74/234) Primary 1, 2, 4, 7, 9, 18 and 20 P85, C2, helical and Kinase Samuels et al (2004)
Colon 13.6 (14/103) Primary 9 and 20 Helical and kinase Velho et al (2005)
Colon 18.8 (6/32) Primary 9 and 20 Helical and kinase Campbell et al (2004)
           
Total colon 25% (94/369)
           
Ovarian 12.1 (24/198) Primary 9 and 20 Helical and kinase Levine et al (2005)
Ovarian 6.0 (11/182) Primary 9 and 20 Helical and kinase Campbell et al (2004)
           
Total ovarian 9% (35/380)
           
Gastric 25.0 (3/12) Primary 18 and 20 Kinase Samuels et al (2004)
Gastric 10.6 (5/47) Primary 9 and 20 Helical and kinase Velho et al (2005)
Gastric 6.5 (12/185) Primary 9 and 20 Helical and kinase Lee et al (2004)
Gastric 4.3 (4/94) Primary 9 and 20 Helical and kinase Li et al (2005)
           
Total gastric 7% (24/338)
           
Brain 26.7 (4/15) Primary 4, 5 and 13 C2 and helical Samuels et al (2004)
Brain 4.6 (13/285) Primary 9 and 20 Helical and kinase Broderick et al (2004)
           
Total brain 6% (17/300)
           
Lung 1.3 (3/229) Primary 9 and 20 Helical and kinase Lee et al (2004)
Lung 4.2 (1/24) Primary 9 Helical Samuels et al (2004)
           
Total lung 2% (4/253)
           
Leukaemia 1.1 (1/88) Primary 9 Helical Lee et al (2004)
           
Total leukaemia 1% (1/88)
Total cancers reported 15% (382/2551)
a

The majority of PIK3CA documented mutations being somatic missense mutations, this table does not include other genetic changes (i.e. gene amplifications, deletions, insertions, etc.).